Introduction a l'immunologie

EPFL, located in the Lausanne area, is a leading European research university focused on science, engineering and technology. Founded in 1853, the school is renowned for interdisciplinary research, strong ties to industry and an entrepreneurial ecosystem that supports hundreds of startups. Students encounter a rigorous curriculum that emphasizes hands-on projects, collaboration and the translation of research into practical solutions.

The campus offers state of the art laboratories, innovation hubs and close partnerships with industry leaders in robotics, AI, sustainable energy and biotechnology. International students join a diverse community and benefit from programs taught in English, extensive research opportunities and structured doctoral and masters pathways. EPFL s connections with Swiss industry create clear pipelines for internships, collaborative theses and employment after graduation.

Life at EPFL blends academic intensity with a supportive environment that includes career services, language support and student associations. Lausanne s location on Lake Geneva provides a high quality of life and plentiful outdoor activities while remaining central to European research networks. Applicants should highlight research interests, teamwork experience and readiness for an intensive, innovation driven academic setting.

The Introduction a l'immunologie program is a non-degree course that introduces students to immunology. It's a one-week online program taught in English at École polytechnique fédérale de Lausanne (EPFL) in Switzerland.

This program covers subjects like immunology basics, immune systems, and immune responses. It helps students develop skills in understanding immune functions and disorders. The program includes interactive components to help students engage with immunology concepts.

Students who complete this program can pursue careers as immunology researchers, laboratory technicians, or health educators. They can work in hospitals, research institutions, or pharmaceutical companies, helping to develop new treatments and therapies.